Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Clinical trial NCT01778803 · COMPLETED
Trial details
- NCT number
- NCT01778803
- Sponsor
- Verastem, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-26
- Primary completion
- 2015-02-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.